Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/30302
Title: Dynamic circulating tumor DNA quantificaton for the individualization of non-small-cell lung cancer patients treatment.
Authors: 
Keywords: 
Issue Date: 1-Sep-2017
Citation: Oncotarget.2017 Sep;(8)36:60291-60298
Abstract: Liquid biopsy has evolved from being a promising line to becoming a validated approach for biomarker testing. However, its utility for individualization of therapy has been scarcely reported. In this study, we show how monitoring levels of EGFR mutation in plasma can be useful for the individualization of treatment.
PMID: 28947971
URI: https://hdl.handle.net/20.500.12530/30302
Rights: openAccess
Appears in Collections:Hospitales > H. U. Infanta Cristina > Artículos
Hospitales > H. U. Puerta de Hierro Majadahonda > Artículos
Fundaciones e Institutos de Investigación > IIS H. U. Puerta de Hierro-Segovia de Arana > Artículos

Files in This Item:
File Description SizeFormat 
PMC5601139.pdf1.32 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.